|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 November 2001, Vol. 98, No. 10, pp. 3022-3029
IMMUNOBIOLOGY
Expression of CCR-7, MIP-3 , and Th-1 chemokines in type I
IFN-induced monocyte-derived dendritic cells: importance for the rapid
acquisition of potent migratory and functional activities
Stefania Parlato,
Stefano
M. Santini,
Caterina Lapenta,
Tiziana Di
Pucchio,
Mariantonia Logozzi,
Massimo Spada,
Anna Maria Giammarioli,
Walter Malorni,
Stefano Fais, and
Filippo Belardelli
From the Laboratory of Virology, Laboratory of
Ultrastructures, and Laboratory of Immunology, Istituto Superiore di
Sanità, Rome, Italy.
The migration capability of dendritic cells (DCs) is regulated by
their response to factors, namely chemokines, that characterize maturation stage and shape their functional activities. This study examines the morphology, expression of chemokines/chemokine receptors, and migration properties of DCs generated after treatment of monocytes with type I interferon (IFN) and granulocyte-macrophage
colony-stimulating factor (GM-CSF) (IFN-DCs). IFN-DCs showed
phenotypical and morphologic features undetectable in DCs generated in
the presence of interleukin 4 (IL-4) and GM-CSF, such as
expression of CD83 and CD25 and the presence of CD44+,
highly polarized, thin, and long dendrites. IFN-DCs markedly migrated
in response to -chemokines (especially MIP-1 ) and expressed the
Th-1 chemokine IP-10. Notably, IFN-DCs showed an up-regulation of CCR7
as well as of its natural ligand MIP-3 , characteristics typical of
mature DCs. Of interest, IFN-DCs exhibited a marked chemotactic
response to MIP-3 in vitro and strong migratory behavior in severe
combined immunodeficient (SCID) mice. In SCID mice reconstituted with
human peripheral blood leukocytes, IFN-DCs induced a potent primary human antibody response and IFN- production, indicative of a
Th-1 immune response. These results define the highly specialized maturation state of IFN-DCs and point out the existence of a "natural alliance" between type I IFN and monocyte/DC development,
instrumental for ensuring an efficient connection between innate and
adaptive immunity.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. R. Anand, A. Prasad, R. R. Bradley, Y. S. Deol, T. Nagaraja, X. Ren, E. F. Terwilliger, and R. K. Ganju
HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1
Blood,
October 22, 2009;
114(17):
3588 - 3600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Scutera, T. Fraone, T. Musso, P. Cappello, S. Rossi, D. Pierobon, Z. Orinska, R. Paus, S. Bulfone-Paus, and M. Giovarelli
Survival and Migration of Human Dendritic Cells Are Regulated by an IFN-{alpha}-Inducible Axl/Gas6 Pathway
J. Immunol.,
September 1, 2009;
183(5):
3004 - 3013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Longhi, C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos, C. Kluger, A. M. Salazar, M. Colonna, and R. M. Steinman
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
J. Exp. Med.,
July 6, 2009;
206(7):
1589 - 1602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gerlini, G. Mariotti, A. Chiarugi, P. Di Gennaro, R. Caporale, A. Parenti, L. Cavone, A. Tun-Kyi, F. Prignano, R. Saccardi, et al.
Induction of CD83+CD14+ Nondendritic Antigen-Presenting Cells by Exposure of Monocytes to IFN-{alpha}
J. Immunol.,
September 1, 2008;
181(5):
2999 - 3008.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Papewalis, B. Jacobs, M. Wuttke, E. Ullrich, T. Baehring, R. Fenk, H. S. Willenberg, S. Schinner, M. Cohnen, J. Seissler, et al.
IFN-{alpha} Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo
J. Immunol.,
February 1, 2008;
180(3):
1462 - 1470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. G. Molenkamp, P. A.M. van Leeuwen, S. Meijer, B. J.R. Sluijter, P. G.J.T.B. Wijnands, A. Baars, A. J.M. van den Eertwegh, R. J. Scheper, and T. D. de Gruijl
Intradermal CpG-B Activates Both Plasmacytoid and Myeloid Dendritic Cells in the Sentinel Lymph Node of Melanoma Patients
Clin. Cancer Res.,
May 15, 2007;
13(10):
2961 - 2969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Noone, E. Manahan, R. Newman, and P. Johnson
Artificially generated dendritic cells misdirect antiviral immune responses
J. Leukoc. Biol.,
April 1, 2007;
81(4):
952 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schott
Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers.
Endocr. Relat. Cancer,
September 1, 2006;
13(3):
779 - 795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Reu, S. I. Bae, L. Cherkassky, D. W. Leaman, D. Lindner, N. Beaulieu, A. R. MacLeod, and E. C. Borden
Overcoming Resistance to Interferon-Induced Apoptosis of Renal Carcinoma and Melanoma Cells by DNA Demethylation
J. Clin. Oncol.,
August 10, 2006;
24(23):
3771 - 3779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Dauer, K. Schad, J. Junkmann, C. Bauer, J. Herten, R. Kiefl, M. Schnurr, S. Endres, and A. Eigler
IFN-{alpha} promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4
J. Leukoc. Biol.,
August 1, 2006;
80(2):
278 - 286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Di Pucchio, L. Pilla, I. Capone, M. Ferrantini, E. Montefiore, F. Urbani, R. Patuzzo, E. Pennacchioli, M. Santinami, A. Cova, et al.
Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-{alpha} Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell Precursors.
Cancer Res.,
May 1, 2006;
66(9):
4943 - 4951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Breckpot, J. Corthals, A. Bonehill, A. Michiels, S. Tuyaerts, C. Aerts, C. Heirman, and K. Thielemans
Dendritic cells differentiated in the presence of IFN-{beta} and IL-3 are potent inducers of an antigen-specific CD8+ T cell response
J. Leukoc. Biol.,
October 1, 2005;
78(4):
898 - 908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Prechtel, N. M. Turza, D. J. Kobelt, J. I. Eisemann, R. S. Coffin, Y. McGrath, C. Hacker, X. Ju, M. Zenke, and A. Steinkasserer
Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration
J. Gen. Virol.,
June 1, 2005;
86(6):
1645 - 1657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Balmelli, N. Ruggli, K. McCullough, and A. Summerfield
Fibrocytes are potent stimulators of anti-virus cytotoxic T cells
J. Leukoc. Biol.,
June 1, 2005;
77(6):
923 - 933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Gauzzi, C. Purificato, K. Donato, Y. Jin, L. Wang, K. C. Daniel, A. A. Maghazachi, F. Belardelli, L. Adorini, and S. Gessani
Suppressive Effect of 1{alpha},25-Dihydroxyvitamin D3 on Type I IFN-Mediated Monocyte Differentiation into Dendritic Cells: Impairment of Functional Activities and Chemotaxis
J. Immunol.,
January 1, 2005;
174(1):
270 - 276.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Tang, L. Zhang, J. Yuan, H. Akbulut, J. Maynard, P.-J. Linton, and A. Deisseroth
Multistep process through which adenoviral vector vaccine overcomes anergy to tumor-associated antigens
Blood,
November 1, 2004;
104(9):
2704 - 2713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Martino, A. Sacchi, N. Sanarico, F. Spadaro, C. Ramoni, A. Ciaramella, L. P. Pucillo, V. Colizzi, and S. Vendetti
Dendritic cells derived from BCG-infected precursors induce Th2-like immune response
J. Leukoc. Biol.,
October 1, 2004;
76(4):
827 - 834.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Okada, T. Tsugawa, H. Sato, N. Kuwashima, A. Gambotto, K. Okada, J. E. Dusak, W. K. Fellows-Mayle, G. D. Papworth, S. C. Watkins, et al.
Delivery of Interferon-{alpha} Transfected Dendritic Cells into Central Nervous System Tumors Enhances the Antitumor Efficacy of Peripheral Peptide-Based Vaccines
Cancer Res.,
August 15, 2004;
64(16):
5830 - 5838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Salek-Ardakani, S. A. Lyons, and J. R. Arrand
Epstein-Barr Virus Promotes Human Monocyte Survival and Maturation through a Paracrine Induction of IFN-{alpha}
J. Immunol.,
July 1, 2004;
173(1):
321 - 331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Carbonneil, H. Saidi, V. Donkova-Petrini, and L. Weiss
Dendritic cells generated in the presence of interferon-{alpha} stimulate allogeneic CD4+ T-cell proliferation: modulation by autocrine IL-10, enhanced T-cell apoptosis and T regulatory type 1 cells
Int. Immunol.,
July 1, 2004;
16(7):
1037 - 1052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Tosi, R. Valenti, A. Cova, G. Sovena, V. Huber, L. Pilla, F. Arienti, F. Belardelli, G. Parmiani, and L. Rivoltini
Role of Cross-Talk between IFN-{alpha}-Induced Monocyte-Derived Dendritic Cells and NK Cells in Priming CD8+ T Cell Responses against Human Tumor Antigens
J. Immunol.,
May 1, 2004;
172(9):
5363 - 5370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Al-khatib, B. R. G. Williams, R. H. Silverman, W. Halford, and D. J. J. Carr
Distinctive Roles for 2',5'-Oligoadenylate Synthetases and Double-Stranded RNA-Dependent Protein Kinase R in the In Vivo Antiviral Effect of an Adenoviral Vector Expressing Murine IFN-{beta}
J. Immunol.,
May 1, 2004;
172(9):
5638 - 5647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Colvin, A. E. Morelli, A. J. Logar, A. H. Lau, and A. W. Thomson
Comparative evaluation of CC chemokine-induced migration of murine CD8{alpha}+ and CD8{alpha}- dendritic cells and their in vivo trafficking
J. Leukoc. Biol.,
February 1, 2004;
75(2):
275 - 285.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gabriele, P. Borghi, C. Rozera, P. Sestili, M. Andreotti, A. Guarini, E. Montefusco, R. Foa, and F. Belardelli
IFN-{alpha} promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatment
Blood,
February 1, 2004;
103(3):
980 - 987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Della Bella, S. Nicola, A. Riva, M. Biasin, M. Clerici, and M. L. Villa
Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-{alpha}
J. Leukoc. Biol.,
January 1, 2004;
75(1):
106 - 116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Santodonato, G. D'Agostino, R. Nisini, S. Mariotti, D. M. Monque, M. Spada, L. Lattanzi, M. Paola Perrone, M. Andreotti, F. Belardelli, et al.
Monocyte-Derived Dendritic Cells Generated After a Short-Term Culture with IFN-{alpha} and Granulocyte-Macrophage Colony-Stimulating Factor Stimulate a Potent Epstein-Barr Virus-Specific CD8+ T Cell Response
J. Immunol.,
May 15, 2003;
170(10):
5195 - 5202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fais and W. Malorni
Leukocyte uropod formation and membrane/cytoskeleton linkage in immune interactions
J. Leukoc. Biol.,
May 1, 2003;
73(5):
556 - 563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. M. de Vries, D. J. E. B. Krooshoop, N. M. Scharenborg, W. J. Lesterhuis, J. H. S. Diepstra, G. N. P. van Muijen, S. P. Strijk, T. J. Ruers, O. C. Boerman, W. J. G. Oyen, et al.
Effective Migration of Antigen-pulsed Dendritic Cells to Lymph Nodes in Melanoma Patients Is Determined by Their Maturation State
Cancer Res.,
January 1, 2003;
63(1):
12 - 17.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Holtl, C. Zelle-Rieser, H. Gander, C. Papesh, R. Ramoner, G. Bartsch, H. Rogatsch, A. L. Barsoum, J. H. Coggin Jr., and M. Thurnher
Immunotherapy of Metastatic Renal Cell Carcinoma with Tumor Lysate-pulsed Autologous Dendritic Cells
Clin. Cancer Res.,
November 1, 2002;
8(11):
3369 - 3376.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hayashi, T. Kaneda, Y. Toyama, M. Kumegawa, and Y. Hakeda
Regulation of Receptor Activator of NF-kappa B Ligand-induced Osteoclastogenesis by Endogenous Interferon-beta (INF-beta ) and Suppressors of Cytokine Signaling (SOCS). THE POSSIBLE COUNTERACTING ROLE OF SOCSs IN IFN-beta -INHIBITED OSTEOCLAST FORMATION
J. Biol. Chem.,
July 26, 2002;
277(31):
27880 - 27886.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|